SCHEMBL29019397

SCHEMBL29019397

Cc1ccc(-c2cc[c]cc2F)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 5/20 0.40
PTGS1 P23219 2/20 0.39
ACHE P22303 2/20 0.36
RPS6KA3 P51812 1/20 0.35
PDE3B Q13370 1/20 0.33
PDE3A Q14432 1/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
NFKB1 P19838 1/20 0.33
RAB9A P51151 1/20 0.33
NFKB2 Q00653 1/20 0.33
KMT2A Q03164 1/20 0.33
RELA Q04206 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TDP1 Q9NUW8 1/20 0.32
BACE1 P56817 1/20 0.31
GCGR P47871 1/20 0.30
MAPK14 Q16539 1/20 0.30
CYP11B1 P15538 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL150097 0.83 PTGS2 (0.35) PTGS2PTGS1RPS6KA3NPC1RAB9A
SCHEMBL4319544 0.83
SCHEMBL435280 0.80 AHR (0.35) PTGS2PTGS1NPC1RAB9ASMN1; SMN2
SCHEMBL1491045 0.80 ALOX5AP (0.33) MEN1KMT2A
SCHEMBL15286357 0.80
SCHEMBL29019414 0.79 AKR1C3 (0.43) PTGS2PTGS1PDE3BPDE3A
SCHEMBL20703486 0.79 AKR1C3 (0.42) MEN1NPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL8074245 0.79 TAAR1 (0.35) NPC1RAB9AKMT2ASMN1; SMN2L3MBTL1
SCHEMBL3544339 0.79 ACHE (0.35) PTGS2PTGS1ACHEMEN1NPC1
SCHEMBL693886 0.79 MEN1 (0.35) PTGS2PTGS1RPS6KA3MEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110003123-B Modulators of the PGI2 receptor for the treatment of prostacyclin (PGI 2) receptor related disorders 艾尼纳制药公司 2023-06-23 CN disclosed